Jagsonpal Pharmaceuticals (India) Top Insiders
JAGSNPHARM | 639.65 23.25 3.77% |
Jagsonpal Pharmaceuticals employs about 1 K people. The company is managed by 7 executives with a total tenure of roughly 2392 years, averaging almost 341.0 years of service per executive, having 146.43 employees per reported executive. Assessment of Jagsonpal Pharmaceuticals' management performance can provide insight into the firm performance.
S Rao Executive Chief Officer |
Nandita Singh Executive Company Officer |
Jagsonpal |
Jagsonpal Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.0605 % which means that it generated a profit of $0.0605 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1326 %, meaning that it generated $0.1326 on every $100 dollars invested by stockholders. Jagsonpal Pharmaceuticals' management efficiency ratios could be used to measure how well Jagsonpal Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Jagsonpal Pharmaceuticals' Non Currrent Assets Other are decreasing as compared to previous years. The Jagsonpal Pharmaceuticals' current Other Current Assets is estimated to increase to about 381.4 M, while Total Assets are projected to decrease to under 1.7 B.The Jagsonpal Pharmaceuticals' current Common Stock Shares Outstanding is estimated to increase to about 28.8 M. The Jagsonpal Pharmaceuticals' current Net Income Applicable To Common Shares is estimated to increase to about 322.7 M
Jagsonpal Pharmaceuticals Workforce Comparison
Jagsonpal Pharmaceuticals Limited is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 10,877. Jagsonpal Pharmaceuticals holds roughly 1,025 in number of employees claiming about 9% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Jagsonpal Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Jagsonpal Pharmaceuticals Price Series Summation is a cross summation of Jagsonpal Pharmaceuticals price series and its benchmark/peer.
Jagsonpal Pharmaceuticals Notable Stakeholders
A Jagsonpal Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Jagsonpal Pharmaceuticals often face trade-offs trying to please all of them. Jagsonpal Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Jagsonpal Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Manish Gupta | MD Director | Profile | |
S Rao | Chief Officer | Profile | |
Nandita Singh | Company Officer | Profile | |
Abhishek Joshi | Company Officer | Profile | |
Bharat Chugh | Assistant Resources | Profile | |
Ashish Lakhotia | Chief Officer | Profile | |
Sudeep Paul | Vice Marketing | Profile |
About Jagsonpal Pharmaceuticals Management Performance
The success or failure of an entity such as Jagsonpal Pharmaceuticals often depends on how effective the management is. Jagsonpal Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Jagsonpal management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Jagsonpal management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Jagsonpal Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Jagsonpal Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Jagsonpal Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Jagsonpal Pharmaceuticals within its industry.Jagsonpal Pharmaceuticals Manpower Efficiency
Return on Jagsonpal Pharmaceuticals Manpower
Revenue Per Employee | 2M | |
Revenue Per Executive | 298.1M | |
Net Income Per Employee | 219.2K | |
Net Income Per Executive | 32.1M | |
Working Capital Per Employee | 1.8M | |
Working Capital Per Executive | 257.3M |
Complementary Tools for Jagsonpal Stock analysis
When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |